TGFb
Showing 1 - 25 of 118
Chitinases and Transforming Growth Factor Beta in Human Asthma
Completed
- Asthma
-
San Francisco, CaliforniaUCSF Airway Clinical Research Center
Jan 29, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8
Terminated
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Bintrafusp Alfa
- Eribulin Mesylate
-
Houston, Texas
- +1 more
Oct 27, 2022
Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic
Recruiting
- Locally Advanced Intrahepatic Cholangiocarcinoma
- +5 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-TGF-beta Monoclonal Antibody SAR-439459
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 2, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Bintrafusp Alfa
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Mar 3, 2022
Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston
Terminated
- Resectable Lung Non-Small Cell Carcinoma
- +10 more
- Bintrafusp Alfa
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jul 27, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +13 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Recurrent Head and Neck Squamous Cell Carcinoma, Second Primary Squamous Cell Carcinoma of the Head and Neck Trial in Houston
Recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- Second Primary Squamous Cell Carcinoma of the Head and Neck
- Bintrafusp Alfa
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2021
Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,
Active, not recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +7 more
- Bintrafusp Alfa
- Docetaxel
-
Scottsdale, Arizona
- +2 more
Nov 3, 2021
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage II Breast Cancer AJCC v8
- +13 more
- Bintrafusp Alfa
-
Houston, TexasM D Anderson Cancer Center
Oct 13, 2021
Carcinoma, Advanced Metastatic Trial in Dallas (TGFß2 Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine)
Terminated
- Carcinoma, Advanced Metastatic
- TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine
-
Dallas, TexasMary Crowley Cancer Research Centers
Feb 27, 2020
Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III
Terminated
- Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
- +9 more
- Bintrafusp Alfa
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2022
Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)
Active, not recruiting
- Lymphoma
- +3 more
- TGFbeta resistant LMP-specific CTLs
-
Houston, Texas
- +1 more
Dec 8, 2021
Burn Degree Second, Burn Degree Third Trial in Jakarta Pusat (Split-thickness skin graft, Artificial skin graft, Artificial skin
Recruiting
- Burn Degree Second
- Burn Degree Third
- Split-thickness skin graft
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSUPN Cipto Mangunkusumo
Dec 8, 2022
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2-Negative Breast Carcinoma
- Biospecimen Collection
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 30, 2023
Celiac Disease Trial in Boston (Gluten powder 4g)
Completed
- Celiac Disease
- Gluten powder 4g
-
Boston, Massachusetts
- +1 more
May 5, 2022
Megakaryocytes and Platelets in Breast Cancer
Not yet recruiting
- Breast Cancer
- Blood draw
- (no location specified)
Aug 21, 2023
Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)
Not yet recruiting
- Focal Segmental Glomerulosclerosis
- Metformin + Standard of Care
- Placebo + Standard of Care
- (no location specified)
Oct 13, 2023
Knee Osteoarthritis Trial (Blueberry powder supplement, Maltodextrin supplementation)
Not yet recruiting
- Knee Osteoarthritis
- Blueberry powder supplement
- Maltodextrin supplementation
- (no location specified)
Mar 13, 2023
Intestinal GVHD, Steroid Refractory GVHD Trial in France (Blood and stool sample collection)
Recruiting
- Intestinal GVHD
- Steroid Refractory GVHD
- Blood and stool sample collection
-
Amiens, France
- +8 more
Jun 20, 2022
Melanoma Trial in Milan (AEP Group Walking Sessions, CEP Group Walking Sessions)
Recruiting
- Melanoma
- AEP Group Walking Sessions
- CEP Group Walking Sessions
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Nov 8, 2022
Anterior Cruciate Ligament Reconstruction Trial in Kaohsiung (Platelet-Rich Plasma; Bone marrow concentrate)
Completed
- Anterior Cruciate Ligament Reconstruction
- Platelet-Rich Plasma; Bone marrow concentrate
-
Kaohsiung, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Jan 3, 2022